LIABLE Act

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1432 Introduced in House (IH)]

<DOC>






119th CONGRESS
  1st Session
                                H. R. 1432

To prohibit any Federal law from making the manufacturer of a COVID-19 
  vaccine immune from suit or liability, or limiting the liability of 
such a manufacturer, with respect to claims for loss caused by, arising 
out of, relating to, or resulting from the administration to or the use 
    by an individual of a COVID-19 vaccine, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 18, 2025

Mr. Roy (for himself, Mr. Massie, Mr. Brecheen, Mr. Cloud, Mr. Higgins 
   of Louisiana, Mr. Crane, Mr. Gosar, and Mr. Perry) introduced the 
  following bill; which was referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL


 
To prohibit any Federal law from making the manufacturer of a COVID-19 
  vaccine immune from suit or liability, or limiting the liability of 
such a manufacturer, with respect to claims for loss caused by, arising 
out of, relating to, or resulting from the administration to or the use 
    by an individual of a COVID-19 vaccine, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Let Injured Americans Be Legally 
Empowered Act'' or the ``LIABLE Act''.

SEC. 2. NO FEDERAL IMMUNITY FROM, OR LIMITATION ON, LIABILITY FOR 
              MANUFACTURERS FOR LOSS CAUSED BY A COVID-19 VACCINE.

    (a) In General.--No Federal law, including sections 319F-3, 2111, 
and 2122 of the Public Health Service Act (42 U.S.C. 247d-6d, 300aa-11, 
300aa-22), may make the manufacturer of a COVID-19 vaccine immune from 
suit or liability, or limit the liability of such a manufacturer, with 
respect to claims for loss caused by, arising out of, relating to, or 
resulting from the administration to or the use by an individual of a 
COVID-19 vaccine.
    (b) Rule of Construction.--Nothing in this Act shall be construed 
to prohibit an individual from seeking compensation through the 
Countermeasures Injury Compensation Program under section 319F-4 of the 
Public Health Service Act (42 U.S.C. 247d-6e) or the National Vaccine 
Injury Compensation Program under subtitle 2 of title XXI of such Act 
(42 U.S.C. 300aa-10 et seq.).
    (c) Relation to Other Programs.--An individual shall not be 
precluded from bringing a civil action for claims described in 
subsection (a) on the basis of such individual having sought or 
received compensation through the Countermeasures Injury Compensation 
Program under section 319F-4 of the Public Health Service Act (42 
U.S.C. 247d-6e) or the National Vaccine Injury Compensation Program 
under subtitle 2 of title XXI of such Act (42 U.S.C. 300aa-10 et seq.).
    (d) Definition.--The term ``COVID-19 vaccine'' means a vaccine 
licensed or otherwise authorized by the Food and Drug Administration to 
prevent, mitigate, or limit--
            (1) the harm from COVID-19; or
            (2) the transmission of SARS-CoV-2 or a virus mutating 
        therefrom.
    (e) Retroactive Applicability.--This Act applies without regard to 
whether the adminstration or use of a COVID-19 vaccine occurs before, 
on, or after the date of enactment of this Act.
                                 <all>